TuHURA Biosciences, Inc.
$1.90-$0.16 (-7.73%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.61% below the high.
OTC · NHIQ · USD
Stock price, earnings
Quote as of Jul 28, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NantHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NantHealth, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NantHealth, Inc., together with its affiliates, operates as a health information technology enterprise providing services throughout the United States, Canada, and the United Kingdom. The company offers Eviti, a software-as-a-service (SaaS) clinical decision support tool that centralizes comprehensive clinical data, along with treatment cost details from Medicare reimbursements and information on therapy toxicity. Eviti Connect utilizes this platform to automate pre-authorization procedures, simplifying the complex process of cancer care for both payers and healthcare providers. Physicians can also access the Eviti platform's extensive collection of evidence-based treatment guidelines and protocols via the Eviti Advisor product, aiding them in making informed therapeutic decisions. Furthermore, NantHealth provides NaviNet, a suite of SaaS-based solutions designed to improve communication and integrate information between healthcare payers and providers. This suite includes NaviNet Open, a collaborative platform for health plans and providers, and NaviNet AllPayer, which offers essential eligibility, benefit, and claim status data to provider offices for both commercial and government plans, as well as for Medicare beneficiaries through the Centers for Medicare and Medicaid Services, all accessible via the NaviNet portal. The company also offers OpenNMS, an open-source network monitoring system tailored for enterprise-level networks. Additionally, NantHealth presents Quadris, a data solution that delivers multi-data analysis, detailed reporting, and expert professional services. Founded in 2010, the company, initially known as Nant Health, LLC, changed its name to NantHealth, Inc. in June 2016. Its main office is located in Morrisville, North Carolina. NantHealth, Inc. functions as a subsidiary of NantWorks, LLC.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2021 | Mar 31, 2022 | -$2.07-53.41% vs estimate | $16.37M-0.32% vs estimate |
|---|
| Q3 2021 | Dec 31, 2021 | -$2.17 | $16.03M |
|---|
KEEP COMPARING
$1.90-$0.16 (-7.73%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.61% below the high.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
$0.01+$0.01 (+100.0%)
Alseres Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Achiko AG: Healthcare · Medical - Healthcare Information Services.
$0.00-$0.82 (-99.99%)
Phoenix Life Sciences International Limited: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.02+CA$0.01 (+50.0%)
Aquarius Surgical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
$0.01$0.00 (0.0%)
Better Plant Sciences Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
Aladdin Healthcare Technologies SE: Healthcare · Medical - Healthcare Information Services.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.